Levothyroxine

CHEBI:CHEBI_753876

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
labeler_name
Aurore Pharmaceuticals Private Limited
application_number
ANDA206163
product_ndc
47781-671
package_marketing_start_date
20070205
package_description
90 TABLET in 1 BOTTLE (0480-8687-98)
manufacturer_name
Piramal Critical Care, Inc.
listing_expiration_date
20241231
marketing_start_date
20070205
spl_id
d4ee6454-f01d-4efe-b089-9a22f876e8c5
generic_name
Levothyroxine and Liothyronine
brand_name
Adthyza thyroid
brand_name_base
Adthyza
route
INTRAVENOUS
package_ndc
50090-4947-1
rxcui
2671600
brand_name_suffix
SOL
pharm_class
l-Triiodothyronine [EPC]
pharm_class_cs
Triiodothyronine [CS]
pharm_class_epc
l-Triiodothyronine [EPC]
upc
0368180965015
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_strength
125 ug/mL
active_ingredient_name
LEVOTHYROXINE SODIUM ANHYDROUS
unii
054I36CPMN
spl_set_id
e293dd94-b523-47a2-8bed-e6d99945ee59
nui
M0021977